Literature DB >> 187943

NIDA's naltrexone research program.

D Julius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187943     DOI: 10.1037/e497452006-004

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


× No keyword cloud information.
  7 in total

Review 1.  Clinical safety of 1500 mg oral naltrexone overdose.

Authors:  Albert Stuart Reece
Journal:  BMJ Case Rep       Date:  2010-09-07

Review 2.  Translational and reverse translational research on the role of stress in drug craving and relapse.

Authors:  Rajita Sinha; Yavin Shaham; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

Review 3.  The pharmacological treatment of opioid addiction--a clinical perspective.

Authors:  Philipp Lobmaier; Michael Gossop; Helge Waal; Jorgen Bramness
Journal:  Eur J Clin Pharmacol       Date:  2010-02-19       Impact factor: 2.953

4.  Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.

Authors:  Gary K Hulse; Robert J Tait; Sandra D Comer; Maria A Sullivan; Ian G Jacobs; Diane Arnold-Reed
Journal:  Drug Alcohol Depend       Date:  2005-09-01       Impact factor: 4.492

Review 5.  The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research.

Authors:  Jennifer M Bossert; Nathan J Marchant; Donna J Calu; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2013-05-18       Impact factor: 4.530

6.  Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.

Authors:  Albert Stuart Reece
Journal:  Subst Abuse       Date:  2012-09-27

Review 7.  Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities.

Authors:  Dennis McCarty; Kelsey C Priest; P Todd Korthuis
Journal:  Annu Rev Public Health       Date:  2017-12-22       Impact factor: 21.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.